<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The EVI1 gene encodes a zinc-finger, DNA-binding protein originally described as the transforming gene associated with a common ecotropic <z:mp ids='MP_0001799'>viral</z:mp> insertion site in myeloid <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Previous studies demonstrated EVI1 expression in human <z:hpo ids='HP_0001909'>leukemias</z:hpo> in cases with 3q26 translocations, but not in <z:mpath ids='MPATH_458'>normal</z:mpath> blood or bone marrow </plain></SENT>
<SENT sid="2" pm="."><plain>These studies also suggested an association between EVI1 expression and chromosome 7 deletion (del) </plain></SENT>
<SENT sid="3" pm="."><plain>Because of this association, we examined expression of EVI1 using <z:chebi fb="40" ids="33697">RNA</z:chebi> polymerase chain reaction (PCR) in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> with and without 3q26 translocations </plain></SENT>
<SENT sid="4" pm="."><plain>EVI1 <z:chebi fb="40" ids="33697">RNA</z:chebi> was expressed in 29% of 34 (95% confidence interval, 20% to 50%) patients with the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> subtypes <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA), <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), or <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>The vast majority of these cases occurred in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>EVI1 expression was not detected in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>), <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow or cord blood, or a variety of other <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>EVI1 <z:chebi fb="40" ids="33697">RNA</z:chebi> was detected in three of 18 patients with <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and in two of four patients with <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> (APL) </plain></SENT>
<SENT sid="8" pm="."><plain>Karyotypes showed that only one <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patient had karyotype 3q26 abnormalities, indicating that EVI1 expression is associated with cases that do not have structural abnormalities involving chromosome 3q26 </plain></SENT>
<SENT sid="9" pm="."><plain>These studies document for the first time the abnormal expression of EVI1 <z:chebi fb="40" ids="33697">RNA</z:chebi> by patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and suggest an important role for EVI1 in the pathogenesis or progression of some <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e> </plain></SENT>
</text></document>